Cinzia Fabro

Udine, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

ANCA-associated vasculitis: a phase-oriented therapeutic framework from immunopathology to precision treatment.

ANCA-associated vasculitis: a phase-oriented therapeutic framework from immunopathology to precision treatment.

Journal: Frontiers in medicine

Published: April 30, 2026

Correlation between colour Doppler activity and parenchymal alterations in salivary glands of patients with primary Sjögren's disease.

Correlation between colour Doppler activity and parenchymal alterations in salivary glands of patients with primary Sjögren's disease.

Journal: Clinical and experimental rheumatology

Published: October 22, 2025

Ultrasonographic scores and parotid histopathology in Sjögren's disease: challenges in lymphoma identification.

Ultrasonographic scores and parotid histopathology in Sjögren's disease: challenges in lymphoma identification.

Journal: Clinical and experimental rheumatology

Published: October 02, 2024

Secretagogue effect of PDE4 inhibitor apremilast on human salivary gland organoids obtained from primary Sjögren's syndrome patients.

Secretagogue effect of PDE4 inhibitor apremilast on human salivary gland organoids obtained from primary Sjögren's syndrome patients.

Journal: Clinical and experimental rheumatology

Published: September 23, 2023

Humoral and T-Cell Mediated Response after the Third Dose of mRNA Vaccines in Patients with Systemic Lupus Erythematosus on Belimumab.

Humoral and T-Cell Mediated Response after the Third Dose of mRNA Vaccines in Patients with Systemic Lupus Erythematosus on Belimumab.

Journal: Journal of clinical medicine

Published: December 16, 2022

Validation of thymic stromal lymphopoietin as a biomarker of primary Sjögren's syndrome and related lymphoproliferation: results in independent cohorts.

Validation of thymic stromal lymphopoietin as a biomarker of primary Sjögren's syndrome and related lymphoproliferation: results in independent cohorts.

Journal: Clinical and experimental rheumatology

Published: August 21, 2020

Thymic stromal lymphopoietin expression from benign lymphoproliferation to malignant B-cell lymphoma in primary Sjögren's syndrome.

Thymic stromal lymphopoietin expression from benign lymphoproliferation to malignant B-cell lymphoma in primary Sjögren's syndrome.

Journal: Clinical and experimental rheumatology

Published: May 02, 2019

Articular and Peripheral Nervous System Involvement Are Linked to the Long-Term Outcome in Primary Sjögren's Syndrome: The Relevance of Single Organ Manifestations Rather Than a Composite Score as Predictors.

Articular and Peripheral Nervous System Involvement Are Linked to the Long-Term Outcome in Primary Sjögren's Syndrome: The Relevance of Single Organ Manifestations Rather Than a Composite Score as Predictors.

Journal: Frontiers in immunology

Published: August 01, 2018

The -308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritis.

The -308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritis.

Journal: The pharmacogenomics journal

Published: November 17, 2014

The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockers.

The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockers.

Journal: Arthritis and rheumatism

Published: April 01, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026